DK403287A - 1,4-dihydropyridinderivater med calciumagonist- og alfa1-antagonist-virkning samt fremgangsmaader til deres fremstilling - Google Patents

1,4-dihydropyridinderivater med calciumagonist- og alfa1-antagonist-virkning samt fremgangsmaader til deres fremstilling

Info

Publication number
DK403287A
DK403287A DK403287A DK403287A DK403287A DK 403287 A DK403287 A DK 403287A DK 403287 A DK403287 A DK 403287A DK 403287 A DK403287 A DK 403287A DK 403287 A DK403287 A DK 403287A
Authority
DK
Denmark
Prior art keywords
magonist
alfa1
procedures
calcium
preparation
Prior art date
Application number
DK403287A
Other languages
Danish (da)
English (en)
Other versions
DK403287D0 (da
Inventor
Alexander Lawrence Johnson
Petrus Bernardus Ma Timmermans
Philip Ma
Ruth Richmond Wexler
Original Assignee
Du Pont
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Du Pont filed Critical Du Pont
Publication of DK403287D0 publication Critical patent/DK403287D0/da
Publication of DK403287A publication Critical patent/DK403287A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/82—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Steroid Compounds (AREA)
  • Silicates, Zeolites, And Molecular Sieves (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK403287A 1986-08-04 1987-08-03 1,4-dihydropyridinderivater med calciumagonist- og alfa1-antagonist-virkning samt fremgangsmaader til deres fremstilling DK403287A (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US89229386A 1986-08-04 1986-08-04
US07/064,361 US4868181A (en) 1986-08-04 1987-06-30 1,4-dihydropyridine derivatives with calcium agonist and alpha1 -antagonist activity

Publications (2)

Publication Number Publication Date
DK403287D0 DK403287D0 (da) 1987-08-03
DK403287A true DK403287A (da) 1988-02-05

Family

ID=26744430

Family Applications (1)

Application Number Title Priority Date Filing Date
DK403287A DK403287A (da) 1986-08-04 1987-08-03 1,4-dihydropyridinderivater med calciumagonist- og alfa1-antagonist-virkning samt fremgangsmaader til deres fremstilling

Country Status (12)

Country Link
US (1) US4868181A (fr)
EP (1) EP0255710A3 (fr)
KR (1) KR930004648B1 (fr)
AU (1) AU617650B2 (fr)
DK (1) DK403287A (fr)
FI (1) FI91634C (fr)
HU (1) HU201925B (fr)
IL (1) IL83413A0 (fr)
NO (1) NO171909C (fr)
NZ (1) NZ221284A (fr)
PT (1) PT85483B (fr)
SU (3) SU1607687A3 (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5137889A (en) * 1983-12-02 1992-08-11 Otsuka Pharmaceutical Co., Ltd. Dihydropyridine derivatives and process for preparing the same
JPS63112560A (ja) * 1986-10-29 1988-05-17 Green Cross Corp:The ジヒドロピリジン誘導体
DE3711991A1 (de) * 1987-04-09 1988-10-20 Bayer Ag Dihydropyridinamide, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
DE3737341A1 (de) * 1987-11-04 1989-05-18 Bayer Ag Neue fluormethoxyphenyl-dihydropyridine, verfahren zur herstellung und ihre verwendung in arzneimitteln
DE3737340A1 (de) * 1987-11-04 1989-05-24 Bayer Ag Neue fluormethoxyphenyl-dihydropyridine, verfahren zur herstellung und ihre verwendung in arzneimitteln
US5106845A (en) * 1990-01-10 1992-04-21 Merrell Dow Pharmaceuticals Inc. Calcium antagonists
CA2009542C (fr) * 1989-02-10 2000-03-14 Albert A. Carr Guanidines cycliques comme antagonistes du calcium
US5166148A (en) * 1990-07-09 1992-11-24 The Du Pont Merck Pharmaceutical Company 2-amino-1,4-dihydropyridine derivatives with calcium agonist and alpha1 -antagonist activity
DE4222770A1 (de) * 1992-07-10 1994-01-13 Bayer Ag Lichtaktivierbare 1-(2-Nitrobenzyl)-substituierte 1,4-Dihydropyridine
IL109220A0 (en) * 1993-04-05 1994-07-31 Synaptic Pharma Corp Dihydropyridines and new uses thereof
US6211198B1 (en) 1993-04-05 2001-04-03 Synaptic Pharmaceutical Corporation Dihydropyridines and new uses thereof
US5767131A (en) * 1993-04-05 1998-06-16 Synaptic Pharmaceutical Corporation Dihydropyridines and new uses thereof
DE4410822A1 (de) * 1994-03-24 1995-09-28 Schering Ag Neue Piperidin-Derivate
US5635503A (en) * 1995-06-07 1997-06-03 Bristol-Myers Squibb Company Dihydropyridine npy antagonists: piperazine derivatives
AU6229099A (en) * 1998-10-23 2000-05-15 Ajinomoto Co., Inc. Dihydropyridine derivatives and drug compositions containing the same
EP2925739A4 (fr) * 2012-11-28 2016-07-27 Stichting Dienst Landbouwkundi Dihydropyridines substituées pour l'embryogenèse somatique dans des plantes

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3985758A (en) * 1973-02-20 1976-10-12 Yamanouchi Pharmaceutical Co., Ltd. 1,4-Dihydropyridine derivatives
DE2752820A1 (de) * 1977-11-26 1979-05-31 Bayer Ag Neue nitrosubstituierte 1,4-dihydropyridine, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE2841667A1 (de) * 1978-09-25 1980-04-10 Bayer Ag Fluorhaltige 1,4-dihydropyridine, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
JPS57171968A (en) * 1981-04-17 1982-10-22 Kyowa Hakko Kogyo Co Ltd 1,4-dihydropyridine derivative
NZ201395A (en) * 1981-07-30 1987-02-20 Bayer Ag Pharmaceutical compositions containing 1,4-dihydropyridines and certain of these dihydropyridines
ATE50987T1 (de) * 1982-05-10 1990-03-15 Takeda Chemical Industries Ltd Dihydropyridinderivate, deren herstellung und verwendung.
DE3377352D1 (en) * 1982-06-03 1988-08-18 Pierrel Spa Dihydropyridines with an antagonistic activity to calcium, process for their preparation, and pharmaceutical compositions containing them
WO1985000169A1 (fr) * 1983-06-21 1985-01-17 Sandoz Ag Derives de 1,4-dihydropyridine, leur fabrication et les preparations pharmaceutiques les contenant
DE3326384A1 (de) * 1983-07-22 1985-01-31 Bayer Ag, 5090 Leverkusen 1,4-dihydropyridine, verfahren zu ihrer herstellung sowie ihre verwendung in arzneimitteln
US4603135A (en) * 1983-10-17 1986-07-29 Takeda Chemical Industries, Ltd. Substituted piperazinyl alkyl esters of 2-amino-4-aryl-1,4-dihydro-6-alkyl-3,5-pyridinedicarboxylates
DE3339861A1 (de) * 1983-11-04 1985-05-15 Bayer Ag, 5090 Leverkusen Arzneizubereitung enthaltend dihydropyridine
JPS60156671A (ja) * 1984-01-25 1985-08-16 Yamanouchi Pharmaceut Co Ltd ジヒドロピリジン誘導体およびその製造法
US4755512A (en) * 1984-04-11 1988-07-05 Bristol-Myers Company Pharmaceutically useful dihydropyridinyldicarboxylate amides and esters incorporating arylpiperazinylalkyl moities
JPS6191185A (ja) * 1984-10-11 1986-05-09 Sumitomo Seiyaku Kk 新規なオキサジアゾリル−１，４−ジヒドロピリジン誘導体
AU5312086A (en) * 1984-12-21 1986-07-22 Byk Gulden Lomberg Chemische Fabrik Gmbh New piperazine derivatives
GB8503427D0 (en) * 1985-02-11 1985-03-13 Ici Plc Basic compounds
DE3521761A1 (de) * 1985-06-19 1987-01-02 Bayer Ag Neue 1,4-dihydropyridine, verfahren zur herstellung und ihre verwendung in arzneimitteln
EP0222702A3 (fr) * 1985-11-06 1988-01-07 Ciba-Geigy Ag Dérivés carbonyliques basiques
DE3600596A1 (de) * 1986-01-11 1987-07-16 Bayer Ag 4-aminoaryldihydropyridinlactone, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
DE3601397A1 (de) * 1986-01-18 1987-07-23 Bayer Ag Substituierte 1,4-dihydropyridin-3-carbonsaeurepiperazide, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
JP2742074B2 (ja) * 1988-11-30 1998-04-22 マツダ株式会社 浸炭炉

Also Published As

Publication number Publication date
NZ221284A (en) 1989-12-21
KR880002827A (ko) 1988-05-11
SU1607687A3 (ru) 1990-11-15
HU201925B (en) 1991-01-28
NO171909B (no) 1993-02-08
SU1609452A3 (ru) 1990-11-23
DK403287D0 (da) 1987-08-03
NO171909C (no) 1993-05-19
AU617650B2 (en) 1991-12-05
PT85483A (en) 1987-09-01
HUT46907A (en) 1988-12-28
NO873240L (no) 1988-02-05
US4868181A (en) 1989-09-19
FI91634B (fi) 1994-04-15
IL83413A0 (en) 1988-01-31
AU7650387A (en) 1988-02-11
EP0255710A2 (fr) 1988-02-10
PT85483B (pt) 1990-06-29
NO873240D0 (no) 1987-08-03
SU1650011A3 (ru) 1991-05-15
FI91634C (fi) 1994-07-25
FI873350A0 (fi) 1987-08-03
EP0255710A3 (fr) 1989-01-04
FI873350A (fi) 1988-02-05
KR930004648B1 (ko) 1993-06-02

Similar Documents

Publication Publication Date Title
DK37089D0 (da) Quinazolinderivater, fremgangsmaader til deres fremstilling samt deres anvendelse
DK120188D0 (da) Aminomethylheterocycler, fremgangsmaader til deres fremstilling samt deres anvendelse
DK316189A (da) Heteroaryloxy-n-isopropylanilider, fremgangsmaade til deres fremstilling samt deres anvendelse
DK52388D0 (da) Polyaminderivater samt fremgangsmaader til deres fremstilling
DK403287D0 (da) 1,4-dihydropyridinderivater med calciumagonist- og alfa1-antagonist-virkning samt fremgangsmaader til deres fremstilling
DK454188A (da) 2-oxo-1-sulfonylaminocarbonyl-azetidiner samt fremgangsmaade til deres fremstilling
DK325487A (da) Farmaceutiske sammensaetninger til parenteral applikation samt deres fremstilling
DK178589A (da) Triazoloaziner, fremgangsmaade til deres fremstilling samt deres anvendelse
DK540887D0 (da) Iminooxazolidiner, fremgangsmaade til deres fremstilling samt anvendelse deraf
DK440688D0 (da) Sulfonylaminoguanidinoaziner, fremgangsmaade til deres fremstilling samt deres anvendelse
DK380787D0 (da) Decahydro-2-naphthylalkylaminer, fremgangsmaade til deres fremstilling samt deres anvendelse
DK386086D0 (da) Substituerede 1,4-dihydro-pyridinderivater samt deres fremstilling og anvendelse
DK630788A (da) N-substituerede dichlormaleinimider, fremgangsmaade til deres fremstiling samt deres anvendelse
DK259089A (da) Aminoguanidinoaziner, fremgangsmaade til deres fremstilling samt deres anvendelse
DK378989D0 (da) Halogenvinylazolderivater, fremgangsmaader til deres fremstilling samt deres anvendelse
DK624288A (da) 3-substituerede pyridiner, fremgangsmaader til deres fremstilling samt deres anvendelse
DK436588D0 (da) Substituerede pyridiner, fremgangsmaader til deres fremstilling samt deres anvendelse
DK264788A (da) Azolyl-tetrahydrofuran-2-yliden-methaner, fremgangsmaader til deres fremstilling samt deres anvendelse
DK63089D0 (da) 1-aminomethyl-3-(2,4-diflour-3-chlorphenyl)-4-cyanopyrroler, fremgangsmaader til deres fremstilling samt deres anvendelse
DK390287D0 (da) Cephalosporiner og derivater deraf samt fremgangsmaader til deres fremstilling
DK208989D0 (da) 3-cyano-4-phenyl-pyrroler, fremgangsmaade til deres fremstilling samt deres anvendelse
DK95389D0 (da) Pyridin-4-carboxylsyreanilider, fremgangsmaader til deres fremstilling samt deres anvendelse
DK84784A (da) Alkylerede benzylidenderivater, fremgangsmaade til deres fremstilling samt deres anvendelse
DK519086A (da) Substituerede 1,1,2-triphenylbut-1-ener, fremgangsmaade til deres fremstilling samt deres anvendelse
DK180488D0 (da) Alkylalkanoater, fremgangsmaade til deres fremstilling samt deres anvendelse